# Acamprosate

## Acamprosate 333mg Delayed-Release\(專案進口\)

| 藥物代碼 | OACAM |
| :--- | :--- |
| 適應症 | Alcoholism, maintenance of abstinence |
| 副作用 | &gt;10%Gastrointestinal: Diarrhea \(10% to 17%\)1% to 10%:Cardiovascular: Chest pain, hypertension, palpitations, peripheral edema, syncope, vasodilationCentral nervous system: Insomnia \(6% to 9%\), anxiety \(5% to 8%\), depression \(4% to 8%\), dizziness \(3% to 4%\), pain \(2% to 4%\), paresthesia \(2% to 3%\), abnormality in thinking, amnesia, attempted suicide, chills, drowsiness, headacheDermatologic: Pruritus \(3% to 4%\), diaphoresis \(2% to 3%\), skin rashEndocrine & metabolic: Decreased libido, weight gainGastrointestinal: Anorexia \(2% to 5%\), nausea \(3% to 4%\), flatulence \(1% to 4%\), xerostomia \(1% to 3%\), abdominal pain, constipation, dysgeusia, dyspepsia, increased appetite, vomitingGenitourinary: ImpotenceInfection: InfectionNeuromuscular & skeletal: Weakness \(5% to 7%\), arthralgia, back pain, myalgia, tremorOphthalmic: Visual disturbanceRespiratory: Bronchitis, dyspnea, flu-like symptoms, increased cough, pharyngitis, rhinitis&lt;1%,postmarketing, and/or case reports: Abnormal hepatic function tests, agitation, alopecia, anemia, angina pectoris, asthma, brain disease, colitis, confusion, deafness, diabetes mellitus, duodenal ulcer, eosinophilia, epistaxis, exfoliative dermatitis, fever, gastrointestinal hemorrhage, gout, hallucination, hemorrhage, hepatic cirrhosis, hepatitis, hostility, hyperbilirubinemia, hyperesthesia, hyperglycemia, hypersensitivity reaction, hyperuricemia, hyponatremia, hypotension, hypothyroidism, increased serum creatinine, increased serum transaminases, leukopenia, lymphadenopathy, lymphocytosis, myocardial infarction, nephrolithiasis, neuralgia, ophthalmic inflammation, orthostatic hypotension, pancreatitis, pneumonia, psychoneurosis, psychosis, pulmonary embolism, rectal hemorrhage, renal failure, seizure, skin photosensitivity, suicidal ideation, tachycardia, thrombocytopenia, urticaria, withdrawal syndrome |
| 禁忌 | Hypersensitivity to acamprosate calcium or any of its components, Severe renal impairment \(CrCl of 30 mL/min or less\). |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest high risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | Micromedex: Infant risk cannot be ruled out. |
| 注射劑給藥建議途徑 | AC, AC15, PC, PO |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

